Twist Bioscience Corporation Announces Pricing of Initial Public Offering
SAN FRANCISCO–(BUSINESS WIRE)–Oct. 30, 2018– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before underwriting discounts and commissions. […]